Eco R1 Capital, LLC Alpine Immune Sciences, Inc. Transaction History

Eco R1 Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.75 - $41.6 $17,750 - $41,600	1,000 New	1,000 $39,000
Q4 2021 Feb 14, 2022	SELL	$10.41 - $13.95 $72,880 - $97,663	-7,001 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.19 - $11.31 $4.22 Million - $5.83 Million	-515,634 Reduced 98.66%	7,001 $75,000
Q2 2021 Aug 16, 2021	SELL	$8.81 - $15.03 $1.93 Million - $3.29 Million	-218,655 Reduced 29.5%	522,635 $4.7 Million
Q3 2020 Nov 16, 2020	BUY	$7.15 - $11.5 $5.3 Million - $8.52 Million	741,290 New	741,290 $6.52 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.